"The Company has now again reached a wonderful milestone. We have successfully implanted OsteoCretein over 1,000 cases throughout in various hospitals and teaching institutions," says BSI president and CEO, .
"OsteoCrete was introduced to me at a time when I was looking for a structural bone void filler that has resorption capabilities as well as prevents subsidence of reduction while having the properties to stimulate natural bone remodeling. It delivered on these expectations and much more. The handling properties and physical characteristics are second to none. I can inject, pack, mold, and even sculpt OsteoCrete to meet any bone void filling need that I encounter in a practice of complex fracture and trauma patients," states , MD Orthopedic trauma surgeon at University Hospitals Cleveland Medical Center and assistant professor at .